Harrington Discovery Institute
Showing of 16 results
New Cause of Diabetes Discovered, Offering Potential Target for New Classes of Drugs to Treat the Disease
Researchers discovered a novel “carrier” enzyme (called SNO-CoA-assisted nitrosylase, or SCAN) that attaches nitric oxide to proteins, including the receptor for insulin action.
The Oxford-Harrington Rare Disease Centre Launches Pioneering Therapeutics Accelerator to Advance Innovative Treatments for Rare Diseases
The Therapeutics Accelerator (the ‘Accelerator’) will identify, fund and advance innovative projects from academic partners in the U.K. and U.S. with the goal to deliver 40 new potentially life-changing therapies for rare diseases into clinical...
UH Harrington Discovery Institute included in partnership to create and fund new gene therapy company focused on inhaled gene therapy to treat rare respiratory diseases.
Harrington Discovery Institute Rare Disease Scholar Award Helps Moves Research Forward
Ten physician-scientists have been selected for drug development grant to advance discoveries into the clinic.
2023 Harrington Prize for Innovation in Medicine Recognizes Pioneering Work in Retinal Gene Therapy for Genetic Diseases.
Newfound clarity on the longstanding “medical mystery” may lead to new line of drugs for oxygen delivery disorders, including peripheral artery disease, sickle cell disease, heart failure, and others.
Oxford-Harrington Rare Disease Centre Hosts Virtual Event on Advancing Novel Therapies for Rare Diseases
Researchers discuss successes in their fields; rare disease family advocate shares story